Last reviewed · How we verify
Levocarnitine Acetyl (ACETYLCARNITINE)
Acetylcarnitine works by supporting the transport of fatty acids into mitochondria, where they can be used for energy production.
Acetylcarnitine (ACETYLCARNITINE) is a carnitine analog, a small molecule drug class. It is used to treat Alzheimer's disease and senile dementia. The commercial status of Acetylcarnitine is unclear, but it has been approved for these indications. Key safety considerations include its low bioavailability of 10%. Further information on its half-life, generic manufacturers, and patent status is not available.
At a glance
| Generic name | ACETYLCARNITINE |
|---|---|
| Drug class | Carnitine Analog |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | discontinued |
Mechanism of action
Think of it like a delivery truck bringing fuel to a power plant. Acetylcarnitine helps the truck (fatty acid transport) get the fuel (fatty acids) to the power plant (mitochondria) where it can be used to produce energy for the body.
Approved indications
- Alzheimer's disease
- Senile dementia
Common side effects
Key clinical trials
- The Effects of Acetyl-L-Carnitine and Myo/Chiro-Inositol in Patients With PCOS (NA)
- Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS (PHASE2,PHASE3)
- LIver FRAilty Management IN Cirrhosis (LIFRAMIN) (NA)
- Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain (PHASE2)
- Clinical Trial to Evaluate Safety and Efficacy of Jalosome® Soothing Gel. (NA)
- Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS (NA)
- To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China (NA)
- Combined Rehabilitation With ALA, ALC, Resveratrol and Vitamin D in Discogenic Sciatica in Young People (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levocarnitine Acetyl CI brief — competitive landscape report
- Levocarnitine Acetyl updates RSS · CI watch RSS